NeuroPace (NPCE) reported Q2 EPS of ($0.52), $0.07 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $11.08 million.
NeuroPace (NPCE) reported Q2 EPS of ($0.52), $0.07 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $10.2 million versus the consensus estimate of $11.08 million.